255 related articles for article (PubMed ID: 15927502)
1. [Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
Grahek D; Barranger E; Daraï E; Uzan S; Talbot JN
Gynecol Obstet Fertil; 2005 Jun; 33(6):371-81. PubMed ID: 15927502
[TBL] [Abstract][Full Text] [Related]
2. PET imaging in gynecologic malignancies.
Kumar R; Alavi A
Radiol Clin North Am; 2004 Nov; 42(6):1155-67, ix. PubMed ID: 15488564
[TBL] [Abstract][Full Text] [Related]
3. [Utilization of PET scan in breast and gynaecologic cancers].
Huglo D; Vinatier D
Gynecol Obstet Fertil; 2004 Apr; 32(4):330-9. PubMed ID: 15123104
[TBL] [Abstract][Full Text] [Related]
4. [Update of 'standards, options and recommendations' for FDG-PET in breast and gynaecological cancers].
Talbot JN; Grahek D
Gynecol Obstet Fertil; 2006 May; 34(5):434-6. PubMed ID: 16677841
[No Abstract] [Full Text] [Related]
5. [2003 update of recommendations for clinical practice: standards, options and recommendations for the use of FDG-PET in the management of gynaecological and breast cancers].
FNCLCC
Gynecol Obstet Fertil; 2004 Apr; 32(4):352-71. PubMed ID: 15123109
[No Abstract] [Full Text] [Related]
6. Positron emission tomography in gynecological malignancies.
Kumar R; Chauhan A; Jana S; Dadparvar S
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1033-44. PubMed ID: 16831075
[TBL] [Abstract][Full Text] [Related]
7. [(18F)-fluoro-2-deoxyglucose PET in imaging of gynecologic cancers].
Talbot JN; Grahek D; Kerrou K; Younsi N; de Beco V; Colombet-Lamau C; Petegnief Y; Cailleux N; Montravers F
Gynecol Obstet Fertil; 2001 Nov; 29(11):775-98. PubMed ID: 11770272
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET in gynaecological cancers: recent observations.
Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2133-9. PubMed ID: 18779962
[No Abstract] [Full Text] [Related]
9. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
[TBL] [Abstract][Full Text] [Related]
10. The Role of PET Imaging in Gynecologic Radiation Oncology.
Rao YJ; Grigsby PW
PET Clin; 2018 Apr; 13(2):225-237. PubMed ID: 29482751
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus].
Bourguet P; Hitzel A; Houvenaeghel G; Vinatier D; Bosquet L; Bonichon F; Corone C; Giard-Lefèvre S; Morett JL; Touboul E; ; ; ; ; ; ; ;
Bull Cancer; 2006 Apr; 93(4):385-90. PubMed ID: 16714228
[No Abstract] [Full Text] [Related]
12. Positron emission tomography scanning in gynecologic and breast cancers.
Zimny M; Siggelkow W
Curr Opin Obstet Gynecol; 2003 Feb; 15(1):69-75. PubMed ID: 12544505
[TBL] [Abstract][Full Text] [Related]
13. [Metabolic imaging with positron-emission tomography in the advanced-stage ovarian cancers].
Grahek D; Hassan-Sebbag N
Bull Cancer; 2009 Dec; 96(12):1163-71. PubMed ID: 19948451
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Assessment of Gynecologic Malignancies.
Tripathy S; Parida GK; Kumar R
PET Clin; 2018 Apr; 13(2):269-288. PubMed ID: 29482754
[No Abstract] [Full Text] [Related]
15. PET/CT in gynecologic malignancies.
Brunetti J
Radiol Clin North Am; 2013 Sep; 51(5):895-911. PubMed ID: 24010912
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET Assessment of Other Gynecologic Cancers.
Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
[TBL] [Abstract][Full Text] [Related]
17. Gynecological cancers.
Avril N; Gourtsoyianni S; Reznek R
Methods Mol Biol; 2011; 727():171-89. PubMed ID: 21331934
[TBL] [Abstract][Full Text] [Related]
18. [Positron emission tomography with 18F-fluorodeoxyglucose in patients with uterine sarcoma].
Rebollo Aguirre AC; Ramos Font C; Bellón Guardia ME; Cabello García D; Gallego Peinado M; Rodríguez Fernández A; Llamas Elvira JM
Rev Esp Med Nucl; 2007; 26(4):189-95. PubMed ID: 17662185
[TBL] [Abstract][Full Text] [Related]
19. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
20. Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
Landheer ML; Steffens MG; Klinkenbijl JH; Westenberg AH; Oyen WJ
Br J Surg; 2005 Nov; 92(11):1363-7. PubMed ID: 16187254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]